Dozens of lawsuits have been filed against the companies behind popular GLP-1 drugs Ozempic, Wegovy and Zepbound, claiming the drugs led to a rare type of vision loss. ABC News' Elizabeth Schulze reports. ▻ ↧ Weight-loss drugs
published
Dozens of lawsuits have been filed against the companies behind popular GLP-1 drugs Ozempic, Wegovy and Zepbound, claiming the drugs led to a rare type of vision loss. ABC News' Elizabeth Schulze reports. ▻
Open the original public source →
Latest documented BWB result
$APP market result
I Sold the $APP $310 Puts for Friday for $3 - been selling Puts on $APP every week with that hard floor of $300 and the high premium
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.